sphingolipid lysosomal storage disorders
lysosomal storage diseases inborn errors metabolism hallmark accumulation storage macromolecules late endocytic system monogenic disorders occur collective frequency live births caused inherited defects genes mainly encode lysosomal proteins commonly lysosomal enzymes subgroup diseases involves lysosomal storage glycosphingolipids understanding genetics biochemistry recently cellular aspects sphingolipid storage disorders gained insights fundamental aspects cell biology otherwise remained opaque addition study disorders led significant progress development therapies several now routine clinical use emerging mechanistic links common diseases suggest need rethink current concept disease boundaries
